BeOne Medicines
The GCO Program Lead at BeOne is accountable for the strategic operational planning and clinical performance of designated oncology programs. This role involves leading global clinical study managers, managing budgets and resources, and ensuring execution excellence across the clinical development lifecycle. The position requires deep therapeutic area expertise and the ability to drive disease/asset strategy in collaboration with cross-functional teams.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1-10 employees
Founded
2010
BeOne Medicines, formerly BeiGene, is committed to advancing cancer care through a science‑led, purpose‑driven model that improves treatment access for patients worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BeOne Medicines.
BeOne Medicines didn’t post a salary, so this is our estimate from similar listings.
5% below the average for this role
Director, GCO Clinical Program Lead (GCPL) – Early Phase
BeOne Medicines
Director, GCO Program Lead (GCPL)
BeOne Medicines
Director, GCO Clinical Program Lead (GCPL)
lifelancer
Associate Director, GCO Program Lead (GCPL), South Korea
BeOne Medicines
Director, GCO Program Lead (GCPL)
BeOne Medicines
Senior Director, GCO Franchise Head
BeOne Medicines